QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
Clinical trial NCT03022825 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03022825
- Sponsor
- ImmunityBio, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-02
- Primary completion
- 2024-10-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.